MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT05856370 | RECRUITING | NA
1000 participants

The Ailliance Post-Market Clinical Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2023-05-01
Completion:
2031-05-31
Conditions
  • Spinal Deformity
  • Spinal Degenerative Disorder
  • Spinal Fusion Failure
  • Spinal Trauma
  • Spinal Tumor Case
Interventions
  • DEVICE
No Results Yet
NCT05791448 | SUSPENDED | PHASE1
36 participants

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2023-03-29
Completion:
2027-03-29
Conditions
  • Advanced Cholangiocarcinoma
  • Advanced Hepatocellular Carcinoma
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Neoplasm in the Liver
  • Refractory Malignant Solid Neoplasm
  • Stage III Hepatocellular Carcinoma AJCC v8
  • Stage IV Hepatocellular Carcinoma AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05492110 | ACTIVE_NOT_RECRUITING | NA
54 participants

Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2023-04-17
Completion:
2026-08-04
Conditions
  • Refractory Angina
  • Microvascular Angina
  • Microvascular Coronary Artery Disease
  • Coronary Disease
  • Angina Pectoris
  • INOCA (Ischemia With Non Obstructive Coronary Artery Disease)
  • ANOCA - Angina With Non-obstructive Coronary Arteries
  • Coronary Microvascular Dysfunction (CMD)
Interventions
  • DEVICE
  • OTHER
  • DIAGNOSTIC_TEST
No Results Yet
NCT05463796 | RECRUITING
5000 participants

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-17
Start Date:
2023-04-25
Completion:
2030-03-25
Conditions
  • Cancer Risk
  • Cancer Predisposition Syndrome
  • Hereditary Cancer Prediction
  • Childhood Cancer Survivors
  • Adult Cancer Survivors
  • IARC Carcinogens
  • Smoking History
  • Lung Cancer
  • Ductal/Lobular Carcinoma
  • Barrett Esophagus
  • Pancreatic Precursor Lesions
  • Colonic Dysplasia/Adenomata
  • Non-Alcoholic Fatty Liver Disease
  • Non Alcoholic Steatohepatitis
  • Cirrhosis
  • High Grade Prostatic Epithelial Neoplasia
  • High-grade Bladder Urothelial Dysplasia/Carcinoma in Situ
  • Adenomatous Hyperplasia
  • High-risk Oral Precancerous Diseases
  • Melanocytic Lesion, Adult
  • Hematologic Malignancy
  • Lung; Node
  • Serous Tubal Intraepithelial Carcinoma
  • Endometrial Intraepithelial Neoplasia
  • Cervical and Endocervical Carcinoma in Situ
  • Vulvar Intraepithelial Neoplasia
  • Nephrogenic Rests
  • Benign Bone Lesions With Risk of Malignant Degeneration
  • Giant Cell Tumor
  • Osteochondroma
  • Spitz Nevus
Interventions
  • OTHER
No Results Yet
NCT05455190 | COMPLETED | NA
209 participants

Parks & Pediatrics Fit Together

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-12-15
Completion:
2026-07-06
Conditions
  • Pediatric Obesity
  • Implementation
Interventions
  • BEHAVIORAL
No Results Yet
NCT05415709 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1
35 participants

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-06-13
Completion:
2026-12-31
Conditions
  • Fallopian Tube Endometrioid Adenocarcinoma
  • Fallopian Tube Mucinous Adenocarcinoma
  • Fallopian Tube Serous Adenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Mucinous Adenocarcinoma
  • Ovarian Serous Adenocarcinoma
  • Primary Peritoneal Endometrioid Adenocarcinoma
  • Primary Peritoneal Serous Adenocarcinoma
  • Stage III Fallopian Tube Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Primary Peritoneal Cancer AJCC v8
  • Stage IIIA Fallopian Tube Cancer AJCC v8
  • Stage IIIA Ovarian Cancer AJCC v8
  • Stage IIIA Primary Peritoneal Cancer AJCC v8
  • Stage IIIA1 Fallopian Tube Cancer AJCC v8
  • Stage IIIA1 Ovarian Cancer AJCC v8
  • Stage IIIA2 Fallopian Tube Cancer AJCC v8
  • Stage IIIA2 Ovarian Cancer AJCC v8
  • Stage IIIB Fallopian Tube Cancer AJCC v8
  • Stage IIIB Ovarian Cancer AJCC v8
  • Stage IIIB Primary Peritoneal Cancer AJCC v8
  • Stage IIIC Fallopian Tube Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
  • Stage IIIC Primary Peritoneal Cancer AJCC v8
  • Stage IV Fallopian Tube Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Primary Peritoneal Cancer AJCC v8
  • Stage IVA Fallopian Tube Cancer AJCC v8
  • Stage IVA Ovarian Cancer AJCC v8
  • Stage IVA Primary Peritoneal Cancer AJCC v8
  • Stage IVB Fallopian Tube Cancer AJCC v8
  • Stage IVB Ovarian Cancer AJCC v8
  • Stage IVB Primary Peritoneal Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
NCT05408845 | RECRUITING | PHASE2
146 participants

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2023-03-03
Completion:
2028-07-31
Conditions
  • Metastatic Salivary Gland Carcinoma
  • Recurrent Salivary Gland Carcinoma
  • Stage III Major Salivary Gland Cancer AJCC v8
  • Stage IV Major Salivary Gland Cancer AJCC v8
  • Unresectable Salivary Gland Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT05401227 | RECRUITING | PHASE1
120 participants

Glutamatergic Mechanisms: Aim2

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-10-15
Completion:
2028-08-31
Conditions
  • Healthy
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page